| Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
|---|
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | WO2005000301A1 2-aminobenzothiazoles as cb1 receptor inverse agonists |
| 01/06/2005 | WO2005000298A2 5-membered heterocycle-based p-38 inhibitors |
| 01/06/2005 | WO2004101573A9 Synthesis of substituted heterocyclic compounds |
| 01/06/2005 | WO2004060281A3 2-aryl thiazole derivatives as kcnq modulators |
| 01/06/2005 | US20050004369 Phenyl substituted carboxylic acids |
| 01/06/2005 | US20050004205 Such as 1-[N alpha -(1'-Acetoxyethoxycarbonyl)-N omega -(pyrazinyl-2-carbonyl)-L-ornithinyl]-pyrrolidine-2-carbonitrile; impaired glucose tolerance, type II diabetes, hypoglycaemia |
| 01/06/2005 | US20050004190 (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]-acetanilide; free base forms; stability; moisture resistance |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |
| 01/06/2005 | US20050004120 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 01/06/2005 | US20050003448 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 01/06/2005 | CA2556706A1 Treatment of amyloid- and epileptogenesis-associated diseases |
| 01/06/2005 | CA2530668A1 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent |
| 01/06/2005 | CA2530662A1 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
| 01/06/2005 | CA2530376A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors |
| 01/06/2005 | CA2529875A1 Biaryloxymethylarene-carboxylic acids |
| 01/06/2005 | CA2528785A1 2-amidobenzothiazoles as cb1 receptor inverse agonists |
| 01/06/2005 | CA2528438A1 P-38 inhibitors |
| 01/06/2005 | CA2526487A1 Heterocyclic methyl sulfone derivative |
| 01/05/2005 | EP1493738A1 Epothilone derivatives |
| 01/05/2005 | EP1493441A1 Therapeutic agent for food competence disorder in stomach |
| 01/05/2005 | EP1492779A1 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 01/05/2005 | EP1492778A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors |
| 01/05/2005 | EP1492777A1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidase inhibitors |
| 01/05/2005 | EP1492773A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation |
| 01/05/2005 | EP1492530A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1561335A Process for preparation of ethene derivatives |
| 01/05/2005 | CN1561327A Novel aminobenzoephenones |
| 01/05/2005 | CN1561246A Compositions of cyclooxygenase-2 selective inhibitors and radiation for inhibition or prevention of cardiovascular disease |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1560038A Compound of substituted benzo heterocyclic by electrophosphorescence and luminous ligand thereof |
| 01/05/2005 | CN1183142C Cynnematin kind antibiotics and composite and use |
| 01/05/2005 | CN1183113C Tri-aryl acid derivatives as PPAR receptor ligands |
| 01/05/2005 | CN1182782C Synergistic herbicidal composition and method for preventing and control of weeds |
| 01/05/2005 | CN1182781C Synergistic herbicidal composition and method for preventing and control of weeds |
| 01/04/2005 | US6838483 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 01/04/2005 | US6838474 Prodrugs of a class of sulfonamides which are aspartyl protease inhibitors. This invention relates to a novel class of prodrugs of HIV aspartyl protease inhibitors characterized by favorable aqueous solubility, high oral bioavailability and |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838439 Heterocytes as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 12/30/2004 | US20040267015 Bactericides |
| 12/30/2004 | US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 12/30/2004 | US20040266856 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 12/30/2004 | US20040266845 Benzothiazolyl derivatives |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266830 Insulin sensitivity enhancer and second antidiabetic of different mechanism; suppressing hyperglycemia |
| 12/30/2004 | US20040266788 treatment of diabetes and/or cancer; useful in the treatment of syndrome X; capable of inhibiting Protein tyrosine phosphatase |
| 12/30/2004 | US20040266784 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 12/29/2004 | WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | WO2004113309A1 Thiazoline derivatives as selective androgen receptor modulators (sarms) |
| 12/29/2004 | WO2004113273A1 Pesticidally active ketone and oxime derivatives |
| 12/29/2004 | WO2004112709A2 Inhibitors of cathepsin s |
| 12/29/2004 | WO2004112701A2 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/29/2004 | WO2004099175A3 Blockers of the quorum sensing system of gram-negative bacteria |
| 12/29/2004 | WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes |
| 12/29/2004 | WO2004056177A3 Insecticidal aminothiazole derivatives |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | EP1491190A1 Decomposition inhibitor for extracellular matrix of cartilage |
| 12/29/2004 | EP1491187A1 Preventive or therapeutic agent for kidney disease |
| 12/29/2004 | EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer |
| 12/29/2004 | EP1282612B1 Alkynyl phenyl heteroaromatic glucokinase activators |
| 12/29/2004 | EP1225882A4 Selective cox-2 inhibitory novel esters from indolealkanols and novel amides from indolealkylamines |
| 12/29/2004 | CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 12/29/2004 | CN1558897A Antidiabetic agents |
| 12/29/2004 | CN1558762A Novel ligands for the HisB10 Zn2+ sites of the R-state insulin hexamer |
| 12/29/2004 | CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 12/29/2004 | CA2527806A1 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/28/2004 | US6835832 Catalytic hydrogenation |
| 12/28/2004 | US6835732 Modulation of the adenosine A2A receptor; cardioprotective agents; antiischemic agents; antihypoxia agents; central nervous system disorders, Alzheimer's disease, Parkinson's disease, anxiolytic agents; antidepressants; analgesics |
| 12/28/2004 | US6835725 Cyanine dye containing heterocylic rings; satisfies light stability, favorable signal/noise rato, damage free application to the substrate material, use in the information layer in a write-once optical data carrier |
| 12/28/2004 | US6835495 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 12/28/2004 | CA2126072C Tri-substituted phenyl derivatives and processes for their preparation |
| 12/23/2004 | WO2004111020A1 Aniline derivatives |
| 12/23/2004 | WO2004110986A1 Benzamide derivative or salt thereof |
| 12/23/2004 | WO2004110983A2 New benzamides as pparϒ modulators |
| 12/23/2004 | WO2004110974A1 Matrix metalloproteinase inhibitors |
| 12/23/2004 | WO2004110418A2 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/23/2004 | WO2004110350A2 Compouds and uses thereof in modulating amyloid beta |
| 12/23/2004 | WO2003095438A9 Substituted phenylacetamides and their use as glucokinase activators |
| 12/23/2004 | WO2003093250A3 Positive allosteric modulators of the nicotinic acetylcholine receptor |
| 12/23/2004 | US20040260098 Synthesis of epothilones, intermediates thereto and analogues thereof |
| 12/23/2004 | US20040260095 human immunodeficiency virus (HIV) protease inhibitors; AIDS; prophylaxis |
| 12/23/2004 | US20040259923 Compound useful as cellular adhesion protein and as antiedemic agent |
| 12/23/2004 | US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence |
| 12/23/2004 | US20040259908 Integrin VLA-4 ( alpha 4 beta 1) and/or integrin LPAM-1 ( alpha 4 beta 7) antagonists, cell adhesion inhibitor; bioavailability, oral administration;treating inflammatory diseases; e.g. 3-[2-(2,6-dichlorobenzoylamino)pyrid-5-yl]-2-{3-[(2,2-dimethylpropionyl)isobutylamino]-4-methoxyphenyl}propionic acid |
| 12/23/2004 | US20040259883 Thiazolidine derivative and medicinal use thereof |
| 12/23/2004 | US20040259877 Inhibitors against the production and release of inflammatory cytokines |
| 12/23/2004 | US20040259804 (Substituted)Acyl dipeptidyl inhibitors of the ICE/ced-3 family of cysteine proteases |
| 12/23/2004 | DE10323701A1 Verfahren zur Synthese heterocyclischer Verbindungen Process for the synthesis of heterocyclic compounds |
| 12/23/2004 | CA2528231A1 New benzamides as ppar.gamma. modulators |
| 12/23/2004 | CA2528003A1 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease |
| 12/23/2004 | CA2527246A1 Aniline derivatives |
| 12/23/2004 | CA2526387A1 Benzamide derivative or salt thereof |
| 12/23/2004 | CA2526285A1 Inhibitors of p38 and methods of using the same |
| 12/22/2004 | EP1489084A1 Broad-spectrum cephem compounds |
| 12/22/2004 | EP1489073A1 Process forpreparation of alkoxybenzamides and thiazolyl isocyanates |
| 12/22/2004 | EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |